Collate

About Collate

Collate is an AI document generation platform for life sciences, automating paperwork across drug, diagnostic, and medical device development. It helps customers bring life-saving innovations to patients faster.

Collate builds an AI document generation platform for life sciences. The platform automates paperwork and powers every step of drug, diagnostic, and medical device development, from concept to market. The company's goal is to help customers get life-saving innovations to patients years faster.

Collate is an early-stage company with $125M in funding from investors including Redpoint, First Round Capital, CRV, Conviction, and Y Combinator. Its leadership includes CEO Surbhi Sarna, a former General Partner at Y Combinator, and CTO Nate Smith, a former Visiting Partner at Y Combinator. The team includes researchers and engineers from Google, Nvidia, Meta, Netflix, Amazon, Airbnb, Hippocratic AI, and Grail, with 40% of the team being former founders.

The company is based in San Francisco and focuses on translating AI research into deployment, with roles spanning AI research, engineering, and product development.